New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT.
Shares of late-stage biopharma company Acurx Pharmaceuticals, Inc. (ACXP) are falling more than 25 percent on Wednesday morning trade, despite reporting positive comparative data from Ibezapolstat from Phase 2b trial in CDI patients.
FMW Media s New to The Street, a national TV show, announces episode 524th airing on the Fox Business Network, Monday, October 23, 2023, at 10:30 PM PT.
Biopharmaceutical company Acurx Pharmaceuticals, Inc. (ACXP) announced Monday that the Company has discontinued the Phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat, for the treatment of patients with Clostridioides difficile infection (CDI) due to success.